The semiconductor industry is recovering from a cyclical downturn, and these two companies stand to benefit.
ASML CEO Christophe Fouquet says the company still sees AI as "a huge opportunity for the industry," but not every semiconductor company is riding the wave. Speaking at the Bloomberg Tech Summit in London, Fouquet adds that he sees 2025 and 2026 as years of "growth" for the industry, but "it's too early to quantify.
ASML's disastrous Q3 earnings torpedoed investor sentiments, but there's a silver lining. ASML's $700 support level has held on firmly, as it's critical for sustaining buying optimism and dip-buying sentiments. Geopolitical uncertainties and declining net bookings have weakened the market's bullish sentiments, but the market isn't dumb.
The semiconductor supplier is experiencing a decline in cash flow from operations, but there is a good reason for that trend.
While the short-term outlook may be difficult, ASML's long-term prospects are solid, driven by its role in semiconductor manufacturing and continued innovation.
We've also got a look at genetic testing company 23andMe.
Chief executive Christophe Fouquet of ASML Holding NV (NASDAQ:ASML), the world leader in semiconductor manufacturing equipment, has suggested stricter controls on the export of its technology to China could be on the agenda. At the behest of the US government, the Dutch government recently barred ASML from shipping its deep ultraviolet (DUV) lithography machines to China.
ASML CEO Christophe Fouquet discusses artificial intelligence, the market in China, as well as US pressure on allies further restrict sales of semiconductor technology to Beijing. Speaking to Tom Giles at the Bloomberg Tech Summit in London, Fouquet also says he is not considering moving a large part of the company's operations outside of the Netherlands.
ASML's Q3 results and guidance led to a 22% share price drop, presenting a buying opportunity due to its essential role in advancing technology. ASML holds a monopoly in EUV lithography, crucial for future chip advancements, and has shown strong long-term performance despite a recent slowdown. The company's financials are solid with minimal debt, strong margins, and efficient asset utilization, making it a robust investment for the long term.
The CEO of leading computer chip equipment maker ASML said on Tuesday he expects the United States government will continue to push for further restrictions on its exports to China.
ASML has returned to growth after revenue declines, with flat revenue expected for 2024 and growth anticipated in 2025, driven by new EUV tools. Despite a 53% QoQ drop in net bookings, ASML's backlog remains strong at €36B, supporting a revised 2025 revenue outlook of €30-35B. Valuation remains neutral in the near-term with a P/E ratio of 35x, but long-term growth prospects make ASML a reasonable multi-year investment.
Q3 2024 results showed notable growth YoY but fell short of expectations, with weak guidance adding to the negativity. ASML's revised 2025 sales guidance and reduced EUV and DUV orders highlight ongoing challenges and geopolitical tensions. Despite a challenging backdrop, ASML shares trade at a premium, making the upcoming Capital Markets Day crucial for future outlook.